Clinical Trial Update: Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating radical surgery followed by precision T-cell immunotherapy targeting multiple tumor-associated antigens for hepatocellu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Precision T Cells Targeting Multiple Tumor-Associated Antigens

Snippet

Sponsor: Second Military Medical University | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: UNKNOWN